Spriewald B M, Witzke O, Wassmuth R, Wenzel R R, Arnold M-L, Philipp T, Kalden J R
Institute for Clinical Immunology, Department of Medicine III, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Ann Rheum Dis. 2005 Mar;64(3):457-61. doi: 10.1136/ard.2004.025809.
Cytokines and T cell regulatory proteins play an important role in the pathogenesis of Wegener's granulomatosis (WG).
To investigate cytokine and cytotoxic T cell antigen-4 (CTLA4) gene polymorphisms and HLA class II alleles in generalised WG.
The distribution of cytokine and cytotoxic T cell antigen 4 (CTLA4) gene polymorphisms and HLA class II alleles was analysed in 32 patients with generalised WG and 91 healthy controls. Genotyping was carried out for HLA-DRB1 and HLA-DQB1 and for polymorphism of the genes encoding TNF alpha (-238, -308, -376), TGF beta (codon 10 and 25), IFN gamma (+874), IL6 (-174), IL10 (-592, -819, -1082), CTLA4 (-318, +49), and the (AT)(n) repeats of the CTLA4 gene. In addition, stratification analysis was carried out according to the presence (n = 15) or absence (n = 17) of end stage renal disease.
An increase in the IFN gamma +874 T/T (odds ratio (OR) = 3.14) and TNF alpha -238 G/A (OR = 5.01) genotypes was found in WG patients. When ESRD positive and negative patients were compared, the IFN gamma +874 A/A and the CTLA4 -318 C/C genotypes were found more often in the ESRD subgroup (OR = 10.6 and OR = 2.25). WG patients without ESRD had a higher frequency of the IL10 GCC/ACC promotor genotype (OR = 0.13) and long CTLA4 (AT)(n) repeats (OR = 0.4). No effect was seen for HLA-DR and -DQ markers.
Disease susceptibility and clinical course in WG may be associated with distinct polymorphisms of cytokine and CTLA4 genes.
细胞因子和T细胞调节蛋白在韦格纳肉芽肿(WG)的发病机制中起重要作用。
研究全身性WG患者的细胞因子和细胞毒性T细胞抗原4(CTLA4)基因多态性以及HLAⅡ类等位基因。
分析32例全身性WG患者和91例健康对照者的细胞因子和细胞毒性T细胞抗原4(CTLA4)基因多态性以及HLAⅡ类等位基因的分布情况。对HLA-DRB1和HLA-DQB1以及编码肿瘤坏死因子α(-238、-308、-376)、转化生长因子β(密码子10和25)、干扰素γ(+874)、白细胞介素6(-174)、白细胞介素10(-592、-819、-1082)、CTLA4(-318、+49)的基因多态性以及CTLA4基因的(AT)n重复序列进行基因分型。此外,根据是否存在终末期肾病(n = 15例存在,n = 17例不存在)进行分层分析。
在WG患者中发现干扰素γ +874 T/T基因型(优势比(OR)= 3.14)和肿瘤坏死因子α -238 G/A基因型(OR = 5.01)增加。比较终末期肾病阳性和阴性患者时,在终末期肾病亚组中更常发现干扰素γ +874 A/A基因型和CTLA4 -318 C/C基因型(OR = 10.6和OR = 2.25)。无终末期肾病的WG患者白细胞介素10 GCC/ACC启动子基因型频率较高(OR = 0.13),且CTLA4(AT)n重复序列较长(OR = 0.4)。未观察到HLA-DR和-DQ标记有影响。
WG的疾病易感性和临床病程可能与细胞因子和CTLA4基因的特定多态性有关。